VitalGo Systems, Ltd. and VitalGo Inc. v. Kreg Therapeutics, LLC is pending as No. 1:26-cv-03144 in the Western District of Texas. The complaint was filed June 3, 2026, in the Eastern District of Virginia, Alexandria Division, as No. 1:26-cv-01533. A June 4, 2026 docket entry records that the case was transferred in from the Alexandria Division, and the Western District of Texas docket identifies the Eastern District of Virginia case as No. 3:26-cv-00521. The complaint says it alleges VitalGo's own acts upon actual knowledge, and all other matters upon information and belief. It says VitalGo Systems, Ltd. is a Cyprus corporation with a principal place of business in Nicosia, Cyprus, and that VitalGo Inc. is a Delaware corporation with a principal place of business in Miramar, Florida. It alleges, on information and belief, that Kreg Therapeutics, LLC is a corporation organized under the laws of Illinois with a principal place of business in Melrose Park, Illinois. The complaint demands a jury under Rule 38 of the Federal Rules of Civil Procedure.
The patent and the accused products
U.S. Patent 8,566,984, Multi-Position Support Apparatus Featuring a Movable Foot Support, issued October 29, 2013, from an application filed February 13, 2012. Google Patents' legal-event record for the '984 patent lists an entry dated December 1, 2025 reading "PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES" and an entry reading "Lapsed due to failure to pay maintenance fee," with an effective date of October 29, 2025. The face of the patent states that it is a continuation-in-part of application No. 11/715,410, filed March 8, 2007, now U.S. Patent 8,117,695. The patent contains seven claims. The complaint alleges that the United States Patent and Trademark Office issued the '984 patent on October 29, 2013, with that title, and that VitalGo holds all rights, title, and interest in and to it, including the right to bring this suit and recover all past damages for infringement during the patent's term, and that Kreg is not licensed under the patent, either expressly or implicitly. The complaint says VitalGo marked its Total Lift Bed with its issued U.S. patent numbers, including U.S. Patent 8,566,984, under 35 U.S.C. § 287(a), and that it has marked those beds since well before March 23, 2020.
The complaint defines the Accused Products as any and all versions of the Catalyst Bed made, used, offered for sale, sold, or imported into the United States by Kreg that infringe the '984 patent, including at least the Catalyst Critical Recovery Bed. It alleges, on information and belief, that the Catalyst Bed appropriates core features of VitalGo's Total Lift Bed, including a moveable foot support for enabling a patient to be moved from a resting position toward a vertical position. It alleges that Kreg's materials for the Catalyst promote Verticalization Therapy and progressive upright positioning and weight-bearing therapy.
What the patent covers
U.S. Patent 8,566,984 covers an apparatus for supporting a user in a resting position and/or a vertical exiting position. Claim 1 covers a tiltable frame assembly tiltably mounted on a base, a body support carried by that frame and having a head end for receiving the upper part of the user's body and a foot end for receiving the lower part, a foot support extending transversely across the foot end of the body support, and drive means for driving the tiltable frame assembly to the resting position and to a substantially vertical exiting position. Claim 1 also covers a processor programmed to cause headward movement of the foot support, thereby engaging the bottom surface of the user's feet when the tiltable frame assembly is in the resting position, and to maintain that feet-engaging position while the tiltable frame assembly is moving towards the vertical position, to prevent sliding of the user's body when the tiltable frame assembly is tilted.
Claims 2 through 7 depend from claim 1. Claim 2 covers a foot sensor that senses the feet-engaging position of the foot support and controls the drive means to maintain the foot support in that position while the tiltable frame assembly is moving towards the vertical position. Claim 3 covers a resting position that includes a substantially horizontal position. Claim 4 covers a resting position that includes a seating position. Claim 5 covers a lifting mechanism between the base and the tiltable frame assembly for selectively supporting the user also in an elevated position. Claim 6 covers a foot support fixed to the tiltable frame assembly to overlie the foot end of the body support, with the body support driven by the drive means to the feet-engaging position. Claim 7 covers a pair of arms fixing opposite sides of the foot support to the tiltable frame assembly. The complaint alleges infringement of at least claim 1.
What the lawsuit alleges
The complaint says that on or about December 2009 VitalGo engaged a predecessor of the defendant as a distributor of Total Lift Beds, and that the predecessor later converted into Kreg Therapeutics, LLC. It says that role ended in May 2011. It alleges that Kreg copied VitalGo's brochure, that in 2010 Kreg's founder demanded intellectual property rights in VitalGo's pending patents in exchange for buying more beds, and that a former VitalGo employee then working for Kreg renewed that demand on two occasions in or about 2010. It alleges that on April 18, 2014 Kreg filed Provisional Application No. 61/981,591, which later matured into U.S. Patent 10,179,077, and that the '077 patent includes the adjustable footrest features of the Total Lift Bed. It alleges that Kreg launched the Catalyst Bed in or about 2016.
Count 1 alleges infringement of U.S. Patent 8,566,984. The complaint alleges that Kreg, in violation of 35 U.S.C. § 271, has directly and indirectly infringed at least claim 1, literally and/or under the doctrine of equivalents, by making, using, offering to sell, selling, and/or importing into the United States, without authority, products including the Catalyst Bed that practice at least claim 1, and by inducing and/or contributing to infringement by others, including third parties that manufacture and/or assemble such products on Kreg's behalf. It alleges that Kreg indirectly infringed at least claim 1 by knowingly encouraging customers to use the Accused Products in an infringing manner, directly or through intermediaries, including through sales, promotional, and marketing materials, product manuals, user guides, and technical support. It alleges that Kreg contributed to infringement of at least claim 1 by selling and providing the Accused Products to customers in the United States for use in practicing that claim, and that those products constitute at least a material part of the invention, are known by Kreg to be especially made or adapted for use in infringing the patent when used for their normal and intended purpose, and are not a staple article or commodity of commerce suitable for substantial noninfringing use.
The complaint attaches a claim chart as Exhibit H and incorporates it. The chart maps claim 1 to the Catalyst Bed. It says the Catalyst bed is an apparatus for supporting a user in a resting position and/or a vertical exiting position, with a tiltable frame assembly tiltably mounted on a base, a body support carried by that frame with a head end and a foot end, and a foot support extending transversely across the foot end of the body support. It says the bed includes drive means for driving the tiltable frame assembly to the resting position and to a substantially vertical exiting position, and it points to a footboard movement control. For the processor limitation, the chart says the Catalyst bed has headward movement of the foot support, thereby engaging the bottom surface of the user's feet when the tiltable frame assembly is in the resting position. It says the bed maintains that feet-engaging position while the tiltable frame assembly is moving towards the vertical position, to prevent sliding of the user's body when the tiltable frame assembly is tilted.
The complaint alleges that Kreg had actual knowledge of the '984 patent at least as of March 25, 2014, when the patent was submitted in an information disclosure statement during prosecution of application 13/050,637. It alleges that the infringement has been willful and deliberate, that VitalGo has been damaged and irreparably harmed, and that the case is exceptional under 35 U.S.C. § 285. It alleges that VitalGo is entitled to damages under 35 U.S.C. § 284.
The prayer asks for a declaration that Kreg has infringed one or more claims of the '984 patent, either literally or under the doctrine of equivalents; an order requiring Kreg to pay damages under 35 U.S.C. §§ 284, 285, 286, and 287, in an amount as yet undetermined, with prejudgment and post-judgment interest, but no less than a reasonable royalty; a declaration that the infringement has been willful since at least as early as March 25, 2014, and enhancing damages under 35 U.S.C. § 284; an award of costs and expenses under 35 U.S.C. § 284 or as otherwise permitted by law; a finding that this is an exceptional case and an award of attorneys' fees under 35 U.S.C. § 285; and such other and further relief, whether legal, equitable, or otherwise, as the court may deem just and appropriate.
Jurisdiction, venue, and the transfer
The complaint alleges that the action arises under the patent laws of the United States, Title 35 of the United States Code, and that the Eastern District of Virginia has subject matter jurisdiction under 28 U.S.C. §§ 1331, 1338(a) and (b), 2201, and 2202. It alleges that venue is proper in that district under 28 U.S.C. § 1400(b) because Kreg has committed acts of infringement there and maintains a regular and established place of business there. It alleges, on information and belief, that Kreg delivers Catalyst beds to hospitals in Northern Virginia and has marketed, demonstrated, and introduced the Catalyst bed in the Alexandria Division, including at facilities in Fairfax, Virginia. It alleges, on information and belief, that Kreg maintains a distribution and service center in Henrico, Virginia. It says Kreg is registered as a foreign limited liability company in Virginia and has a designated agent for service in Glen Allen, Virginia.
On June 29, 2026, Kreg filed a motion to transfer, stay, or dismiss. VitalGo opposed the motion on July 13, 2026, and Kreg replied on July 20, 2026. The November 10, 2026 memorandum order, signed by District Judge David J. Novak, states that the interests of justice favor transferring the action to the Western District of Texas. It grants the motion insofar as it seeks transfer under 28 U.S.C. § 1404(a), directs the clerk to transfer the case, denies the request for a stay as moot, and declines to address the arguments for dismissal under Federal Rules of Civil Procedure 12(b)(3) and 12(b)(6), without prejudice to a motion in the transferee court.
The parties were already in the Western District of Texas. On April 10, 2026, Kreg Therapeutics, LLC and a second plaintiff filed Kreg Therapeutics, LLC v. VitalGo Systems, Ltd., No. 1:26-cv-00895, against VitalGo Systems, Ltd. and other defendants. That case is assigned to Judge Alan D. Albright, and the docket lists its cause as patent infringement under 35 U.S.C. § 271.
What to watch next
Watch for Kreg's answer or a motion in the Western District of Texas, for a scheduling order, and for any order relating this case to No. 1:26-cv-00895. The case can end at any time, including by settlement or voluntary dismissal.